Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides

Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with...

Full description

Saved in:
Bibliographic Details
Published in:Journal of endocrinological investigation Vol. 44; no. 3; pp. 547 - 555
Main Authors: Mantovani, A., Danese, E., Salvagno, G. L., Gelati, M., Turino, T., Bovo, C., Lippi, G., Targher, G.
Format: Journal Article
Language:English
Published: Cham Springer International Publishing 01-03-2021
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. Patients and methods We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. Results In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s r coefficient = − 0.228, p  = 0.039) and EPT ( r  = − 0.293, p  = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. Conclusion Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides.
AbstractList OBJECTIVEPrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. PATIENTS AND METHODSWe studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6-19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. RESULTSIn univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson's r coefficient = - 0.228, p = 0.039) and EPT (r = - 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. CONCLUSIONOur findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides.
Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6-19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson's r coefficient = - 0.228, p = 0.039) and EPT (r = - 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides.
Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. Patients and methods We studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. Results In univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s r coefficient = − 0.228, p  = 0.039) and EPT ( r  = − 0.293, p  = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides. Conclusion Our findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides.
ObjectivePrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with and without type 2 diabetes mellitus (T2DM). Presently, it is uncertain whether lower plasma adiponectin levels are associated with greater plasma thrombin generation in patients with T2DM. Patients and methodsWe studied 82 middle-aged men with non-insulin-treated T2DM [mean age ± SD: 64.1 ± 8 years; median duration of diabetes: 12.5 (inter-quartile range 6–19) years; mean hemoglobin A1c 7.0 ± 0.7%], consecutively attending our diabetes outpatient service over a 6-month period. Using the newly developed fully automated thrombin generation analyzer ST Genesia®, we measured the plasma parameters lag time (LT), time to peak (TP), peak height (PH) and endogenous thrombin potential (ETP) in all participants. ResultsIn univariable linear regression analyses, lower plasma adiponectin levels were significantly associated with higher plasma thrombin generation parameters, as reflected by higher values of PH (Pearson’s r coefficient = − 0.228, p = 0.039) and EPT (r = − 0.293, p = 0.007). Plasma adiponectin levels were not significantly associated with other thrombin generation parameters (LT and TP). Notably, the significant associations of plasma adiponectin levels with thrombin PH and EPT values persisted after adjustment for age and adiposity measures, but they were lost after additional adjustment for plasma triglycerides.ConclusionOur findings show for the first time the existence of a significant association between lower levels of plasma adiponectin and greater plasma thrombin generation (as assessed by the ST Genesia® analyzer) in men with non-insulin-treated T2DM, which appears to be largely mediated by plasma triglycerides.
Author Targher, G.
Danese, E.
Mantovani, A.
Lippi, G.
Salvagno, G. L.
Bovo, C.
Gelati, M.
Turino, T.
Author_xml – sequence: 1
  givenname: A.
  surname: Mantovani
  fullname: Mantovani, A.
  email: alessandro.mantovani@univr.it
  organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 2
  givenname: E.
  surname: Danese
  fullname: Danese, E.
  organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 3
  givenname: G. L.
  surname: Salvagno
  fullname: Salvagno, G. L.
  organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 4
  givenname: M.
  surname: Gelati
  fullname: Gelati, M.
  organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 5
  givenname: T.
  surname: Turino
  fullname: Turino, T.
  organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 6
  givenname: C.
  surname: Bovo
  fullname: Bovo, C.
  organization: Medical Direction, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 7
  givenname: G.
  surname: Lippi
  fullname: Lippi, G.
  organization: Section of Clinical Biochemistry, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
– sequence: 8
  givenname: G.
  surname: Targher
  fullname: Targher, G.
  organization: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32588382$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv3CAUhVGVKu8_0EWE1E03bnnYBrKLojatFKmbZI0wvp4hssEBpqP5M_2tJXFeyqIr4J7vnoN0jtCeDx4Q-kTJV0qI-JZq0lJZEUYqQnlNKv4BHVJRnpLLdu_N_QAdpXRHCBdcin10wFkjy5wdor8XKQXrTHbB4w7yFsDjMWwh4nk0aTLY9G4uuTa7IsAfGBM2vsdrt1q_Qnkdw9QVYgUe4uI2m2gmyBATLsJUfLcur3HezYAZ7p0pcZDOcQwj4DC8WEW3GncWoushnaCPgxkTnD6dx-j2x_eby5_V9e-rX5cX15XlosmVbQyrhRqolYoB7TtpDAgBA-951xlKhZJqAMVrYA0bGkWJ6hquoDdWQVvzY_Rl8Z1juN9AynpyycI4Gg9hkzSrqaRMtEQW9PM79C5soi-_K5SUrWJMNoViC2VjSCnCoOfoJhN3mhL90J5e2tOlPf3YnuZl6ezJetNN0L-sPNdVAL4AqUh-BfE1-z-2_wCCJaop
CitedBy_id crossref_primary_10_1111_jth_15657
crossref_primary_10_1007_s42000_022_00387_6
crossref_primary_10_3390_nu13061774
Cites_doi 10.1007/s11239-013-1026-5
10.1530/EJE-09-0958
10.1055/s-0030-1248723
10.1055/s-0037-1608942
10.1161/01.ATV.0000048856.22331.50
10.1016/S0140-6736(14)61177-6
10.1210/jc.2006-1067
10.1111/obr.12064
10.7326/0003-4819-150-9-200905050-00006
10.1111/j.1463-1326.2005.00510.x
10.1001/jama.291.14.1730
10.1515/cclm-2019-0135
10.1159/000071636
10.3390/ijms20051190
10.1093/eurheartj/ehz455
10.1159/000480006
10.1038/nrcardio.2017.31
10.1016/j.atherosclerosis.2011.07.011
10.1016/j.metabol.2006.08.005
10.1097/MD.0000000000004495
10.1074/jbc.270.45.26746
10.1111/j.1365-2265.2006.02527.x
10.1152/ajpendo.00728.2009
10.1111/j.1538-7836.2012.04782.x
10.1373/clinchem.2015.248625
10.1186/s12944-019-1168-3
10.2337/dc19-S011
10.1016/j.diabet.2019.11.004
10.3390/ijms18061321
ContentType Journal Article
Copyright Italian Society of Endocrinology (SIE) 2020
Italian Society of Endocrinology (SIE) 2020.
Copyright_xml – notice: Italian Society of Endocrinology (SIE) 2020
– notice: Italian Society of Endocrinology (SIE) 2020.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1007/s40618-020-01340-3
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1720-8386
EndPage 555
ExternalDocumentID 10_1007_s40618_020_01340_3
32588382
Genre Journal Article
GroupedDBID ---
-EM
.GJ
203
4.4
406
53G
5GY
5RE
8RF
8YF
96X
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
AAZMS
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABMQK
ABPLI
ABQBU
ABTEG
ABTKH
ABTMW
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACIGE
ACIPQ
ACKNC
ACMLO
ACOKC
ACPRK
ACTTH
ACUDM
ACVWB
ACWMK
ADHHG
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADURQ
ADYFF
ADZKW
AEBTG
AEEQQ
AEFTE
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEODN
AEOHA
AEPYU
AESKC
AESTI
AETCA
AEVLU
AEVTX
AEXYK
AFAFS
AFNRJ
AFQWF
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGKHE
AGMZJ
AGQMX
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHSBF
AI.
AIAKS
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKLTO
AKMHD
AKQUC
ALFXC
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
AMYQR
ANMIH
ASPBG
AUKKA
AVWKF
AXYYD
AZFZN
BGNMA
CSCUP
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
ESBYG
F5P
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FYJPI
GGCAI
GGRSB
GJIRD
GQ6
GQ7
GRRUI
HG6
HRMNR
I0C
IKXTQ
IMOTQ
ITM
IWAJR
J-C
JBSCW
JZLTJ
KOV
LLZTM
M4Y
NPVJJ
NQJWS
NU0
O93
O9G
O9J
P2P
PT4
RHV
RLLFE
RSV
SCLPG
SDE
SHX
SISQX
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
TSG
U9L
UG4
UOJIU
UTJUX
UZXMN
VFIZW
VH1
W48
Z7U
Z7W
Z82
Z83
Z87
ZA5
ZGI
ZMTXR
ZOVNA
ZXP
0R~
AACDK
AAEOY
AAEWM
AAJBT
AASML
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
NPM
ROL
SJYHP
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c375t-c5a2479f1c892e1db8aae77ef3d3bba117989fe934e252f59109b539edac9e643
IEDL.DBID AEJHL
ISSN 1720-8386
0391-4097
IngestDate Fri Oct 25 02:42:10 EDT 2024
Thu Nov 21 04:11:09 EST 2024
Thu Nov 21 21:27:15 EST 2024
Sat Sep 28 08:29:31 EDT 2024
Sat Dec 16 12:10:05 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Type 2 diabetes
Triglycerides
Plasma thrombin generation
Adiponectin
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-c5a2479f1c892e1db8aae77ef3d3bba117989fe934e252f59109b539edac9e643
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 32588382
PQID 2488692285
PQPubID 2043718
PageCount 9
ParticipantIDs proquest_miscellaneous_2418127608
proquest_journals_2488692285
crossref_primary_10_1007_s40618_020_01340_3
pubmed_primary_32588382
springer_journals_10_1007_s40618_020_01340_3
PublicationCentury 2000
PublicationDate 2021-03-01
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: 2021-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Italy
– name: Heidelberg
PublicationSubtitle Official Journal of Italian Society of Endocrinology (SIE)
PublicationTitle Journal of endocrinological investigation
PublicationTitleAbbrev J Endocrinol Invest
PublicationTitleAlternate J Endocrinol Invest
PublicationYear 2021
Publisher Springer International Publishing
Springer Nature B.V
Publisher_xml – name: Springer International Publishing
– name: Springer Nature B.V
References Reiner (CR25) 2017; 14
Ebrahimi-Mamaeghani, Mohammadi, Arefhosseini, Fallah, Bazi (CR5) 2015; 11
Scherer, Williams, Fogliano, Baldini, Lodish (CR1) 1995; 270
CR16
Hemker, Giesen, Al Dieri, Regnault, de Smedt, Wagenvoord, Lecompte, Béguin (CR15) 2003; 33
Mach, Baigent, Catapano, Koskinas, Casula, Badimon, Chapman, De Backer, Delgado, Ference, Graham, Halliday, Landmesser, Mihaylova, Pedersen, Riccardi, Richter, Sabatine, Taskinen, Tokgozoglu, Wiklund (CR27) 2020; 41
Yang, Li, Zhao, Zhang (CR10) 2019; 18
Chitongo, Roberts, Yang, Patel, Lyall, Luxton, Aylwin, Arya (CR19) 2017; 1
Targher, Zoppini, Moghetti, Day (CR28) 2010; 36
Levey, Stevens, Schmid, Zhang, Castro, Feldman, Kusek, Eggers, Van Lente, Greene, Coresh (CR17) 2009; 150
Pischon, Girman, Hotamisligil, Rifai, Hu, Rimm (CR9) 2004; 291
Christou, Kiortsis (CR22) 2013; 14
(CR18) 2019; 42
Chen, Zheng, Liu, Lin, Liao, Xin, Zhong, Cheng, Zhang (CR24) 2017; 42
Franchini, Lippi, Manzato, Vescovi, Targher (CR29) 2010; 162
CR2
Targher, Bertolini, Rodella, Zoppini, Scala, Zenari, Falezza (CR4) 2006; 64
Tripodi (CR14) 2016; 62
Pischon, Hu, Girman, Rifai, Manson, Rexrode, Rimm (CR20) 2011; 219
Kalz, ten Cate, Spronk (CR11) 2014; 37
Salvagno, Favaloro, Demonte, Gelati, Poli, Targher, Lippi (CR13) 2019; 57
Kumada, Kihara, Sumitsuji, Kawamoto, Matsumoto, Ouchi, Arita, Okamoto, Shimomura, Hiraoka, Nakamura, Funahashi, Matsuzawa (CR6) 2003; 23
Frystyk, Berne, Berglund, Jensevik, Flyvbjerg, Zethelius (CR7) 2007; 92
Hashimoto, Kanda, Nakamura, Horie, Kurosawa, Hashimoto, Sato, Kushida, Suzuki, Yano, Iwai, Takahashi, Yoshida (CR8) 2006; 55
Restituto, Colina, Varo, Varo (CR23) 2010; 298
Nordestgaard, Varbo (CR26) 2014; 384
Loeffen, Spronk, ten Cate (CR12) 2012; 10
Yanai, Yoshida (CR21) 2019; 20
Mi, Yan, Lu, Liang, Li (CR30) 2016; 95
Whitehead, Richards, Hickman, Macdonald, Prins (CR3) 2006; 8
PE Scherer (1340_CR1) 1995; 270
HC Hemker (1340_CR15) 2003; 33
AS Levey (1340_CR17) 2009; 150
G Targher (1340_CR28) 2010; 36
1340_CR2
JP Whitehead (1340_CR3) 2006; 8
M Ebrahimi-Mamaeghani (1340_CR5) 2015; 11
G Targher (1340_CR4) 2006; 64
L Yang (1340_CR10) 2019; 18
T Pischon (1340_CR20) 2011; 219
Y Mi (1340_CR30) 2016; 95
H Yanai (1340_CR21) 2019; 20
PB Chitongo (1340_CR19) 2017; 1
P Restituto (1340_CR23) 2010; 298
Y Chen (1340_CR24) 2017; 42
R Loeffen (1340_CR12) 2012; 10
F Mach (1340_CR27) 2020; 41
Ž Reiner (1340_CR25) 2017; 14
BG Nordestgaard (1340_CR26) 2014; 384
American Diabetes Association (1340_CR18) 2019; 42
J Frystyk (1340_CR7) 2007; 92
1340_CR16
M Franchini (1340_CR29) 2010; 162
T Pischon (1340_CR9) 2004; 291
N Hashimoto (1340_CR8) 2006; 55
M Kumada (1340_CR6) 2003; 23
A Tripodi (1340_CR14) 2016; 62
GA Christou (1340_CR22) 2013; 14
GL Salvagno (1340_CR13) 2019; 57
J Kalz (1340_CR11) 2014; 37
References_xml – volume: 37
  start-page: 45
  year: 2014
  end-page: 55
  ident: CR11
  article-title: Thrombin generation and atherosclerosis
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-013-1026-5
  contributor:
    fullname: Spronk
– volume: 162
  start-page: 439
  year: 2010
  end-page: 451
  ident: CR29
  article-title: Hemostatic abnormalities in endocrine and metabolic disorders
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0958
  contributor:
    fullname: Targher
– volume: 36
  start-page: 41
  year: 2010
  end-page: 48
  ident: CR28
  article-title: Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0030-1248723
  contributor:
    fullname: Day
– volume: 11
  start-page: 55
  year: 2015
  end-page: 70
  ident: CR5
  article-title: Adiponectin as a potential biomarker of vascular disease
  publication-title: Vasc Health Risk Manag
  contributor:
    fullname: Bazi
– ident: CR2
– ident: CR16
– volume: 1
  start-page: e146
  year: 2017
  end-page: e154
  ident: CR19
  article-title: Visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity
  publication-title: TH Open
  doi: 10.1055/s-0037-1608942
  contributor:
    fullname: Arya
– volume: 23
  start-page: 85
  year: 2003
  end-page: 89
  ident: CR6
  article-title: Association of hypoadiponectinemia with coronary artery disease in men
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000048856.22331.50
  contributor:
    fullname: Matsuzawa
– volume: 384
  start-page: 626
  year: 2014
  end-page: 635
  ident: CR26
  article-title: Triglycerides and cardiovascular disease
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61177-6
  contributor:
    fullname: Varbo
– volume: 92
  start-page: 571
  year: 2007
  end-page: 576
  ident: CR7
  article-title: Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-1067
  contributor:
    fullname: Zethelius
– volume: 14
  start-page: 939
  year: 2013
  end-page: 949
  ident: CR22
  article-title: Adiponectin and lipoprotein metabolism
  publication-title: Obes Rev
  doi: 10.1111/obr.12064
  contributor:
    fullname: Kiortsis
– volume: 150
  start-page: 604
  year: 2009
  end-page: 612
  ident: CR17
  article-title: A new equation to estimate glomerular filtration rate
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
  contributor:
    fullname: Coresh
– volume: 8
  start-page: 264
  year: 2006
  end-page: 280
  ident: CR3
  article-title: Adiponectin-a key adipokine in the metabolic syndrome
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2005.00510.x
  contributor:
    fullname: Prins
– volume: 291
  start-page: 1730
  year: 2004
  end-page: 1737
  ident: CR9
  article-title: Plasma adiponectin levels and risk of myocardial infarction in men
  publication-title: JAMA
  doi: 10.1001/jama.291.14.1730
  contributor:
    fullname: Rimm
– volume: 57
  start-page: 1784
  year: 2019
  end-page: 1789
  ident: CR13
  article-title: Influence of hypertriglyceridemia, hyperbilirubinemia and hemolysis on thrombin generation in human plasma
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2019-0135
  contributor:
    fullname: Lippi
– volume: 33
  start-page: 4
  year: 2003
  end-page: 15
  ident: CR15
  article-title: Calibrated automated thrombin generation measurement in clotting plasma
  publication-title: Pathophysiol Haemost Thromb
  doi: 10.1159/000071636
  contributor:
    fullname: Béguin
– volume: 20
  start-page: 1190
  year: 2019
  ident: CR21
  article-title: beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20051190
  contributor:
    fullname: Yoshida
– volume: 41
  start-page: 111
  year: 2020
  end-page: 188
  ident: CR27
  article-title: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehz455
  contributor:
    fullname: Wiklund
– volume: 42
  start-page: 2342
  year: 2017
  end-page: 2352
  ident: CR24
  article-title: Adiponectin inhibits TNF-α-activated PAI-1 expression via the cAMP-PKA-AMPK-NF-κB axis in human umbilical vein endothelial cells
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000480006
  contributor:
    fullname: Zhang
– volume: 14
  start-page: 401
  year: 2017
  end-page: 411
  ident: CR25
  article-title: Hypertriglyceridaemia and risk of coronary artery disease
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2017.31
  contributor:
    fullname: Reiner
– volume: 219
  start-page: 322
  year: 2011
  end-page: 329
  ident: CR20
  article-title: Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.07.011
  contributor:
    fullname: Rimm
– volume: 55
  start-page: 1653
  year: 2006
  end-page: 1657
  ident: CR8
  article-title: Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2006.08.005
  contributor:
    fullname: Yoshida
– volume: 95
  start-page: e4495
  year: 2016
  ident: CR30
  article-title: Venous thromboembolism has the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000004495
  contributor:
    fullname: Li
– volume: 270
  start-page: 26746
  year: 1995
  end-page: 26749
  ident: CR1
  article-title: A novel serum protein similar to c1q, produced exclusively in adipocytes
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.45.26746
  contributor:
    fullname: Lodish
– volume: 64
  start-page: 679
  year: 2006
  end-page: 683
  ident: CR4
  article-title: Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2006.02527.x
  contributor:
    fullname: Falezza
– volume: 298
  start-page: E1072
  year: 2010
  end-page: 1077
  ident: CR23
  article-title: Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00728.2009
  contributor:
    fullname: Varo
– volume: 10
  start-page: 1207
  year: 2012
  end-page: 1216
  ident: CR12
  article-title: The impact of blood coagulability on atherosclerosis and cardiovascular disease
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2012.04782.x
  contributor:
    fullname: ten Cate
– volume: 62
  start-page: 699
  year: 2016
  end-page: 707
  ident: CR14
  article-title: Thrombin generation assay and its application in the clinical laboratory
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2015.248625
  contributor:
    fullname: Tripodi
– volume: 18
  start-page: 227
  year: 2019
  ident: CR10
  article-title: Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysis
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-019-1168-3
  contributor:
    fullname: Zhang
– volume: 42
  start-page: S124
  issue: suppl 1
  year: 2019
  end-page: S138
  ident: CR18
  article-title: Microvascular complications and foot care: standards of medical care in diabetes-2019
  publication-title: Diabetes Care
  doi: 10.2337/dc19-S011
– volume: 298
  start-page: E1072
  year: 2010
  ident: 1340_CR23
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00728.2009
  contributor:
    fullname: P Restituto
– volume: 8
  start-page: 264
  year: 2006
  ident: 1340_CR3
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2005.00510.x
  contributor:
    fullname: JP Whitehead
– volume: 11
  start-page: 55
  year: 2015
  ident: 1340_CR5
  publication-title: Vasc Health Risk Manag
  contributor:
    fullname: M Ebrahimi-Mamaeghani
– volume: 1
  start-page: e146
  year: 2017
  ident: 1340_CR19
  publication-title: TH Open
  doi: 10.1055/s-0037-1608942
  contributor:
    fullname: PB Chitongo
– volume: 55
  start-page: 1653
  year: 2006
  ident: 1340_CR8
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2006.08.005
  contributor:
    fullname: N Hashimoto
– volume: 291
  start-page: 1730
  year: 2004
  ident: 1340_CR9
  publication-title: JAMA
  doi: 10.1001/jama.291.14.1730
  contributor:
    fullname: T Pischon
– volume: 95
  start-page: e4495
  year: 2016
  ident: 1340_CR30
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000004495
  contributor:
    fullname: Y Mi
– volume: 10
  start-page: 1207
  year: 2012
  ident: 1340_CR12
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2012.04782.x
  contributor:
    fullname: R Loeffen
– volume: 64
  start-page: 679
  year: 2006
  ident: 1340_CR4
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2006.02527.x
  contributor:
    fullname: G Targher
– volume: 23
  start-page: 85
  year: 2003
  ident: 1340_CR6
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000048856.22331.50
  contributor:
    fullname: M Kumada
– volume: 92
  start-page: 571
  year: 2007
  ident: 1340_CR7
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2006-1067
  contributor:
    fullname: J Frystyk
– ident: 1340_CR16
  doi: 10.1016/j.diabet.2019.11.004
– volume: 36
  start-page: 41
  year: 2010
  ident: 1340_CR28
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0030-1248723
  contributor:
    fullname: G Targher
– volume: 57
  start-page: 1784
  year: 2019
  ident: 1340_CR13
  publication-title: Clin Chem Lab Med
  doi: 10.1515/cclm-2019-0135
  contributor:
    fullname: GL Salvagno
– volume: 384
  start-page: 626
  year: 2014
  ident: 1340_CR26
  publication-title: Lancet
  doi: 10.1016/S0140-6736(14)61177-6
  contributor:
    fullname: BG Nordestgaard
– volume: 162
  start-page: 439
  year: 2010
  ident: 1340_CR29
  publication-title: Eur J Endocrinol
  doi: 10.1530/EJE-09-0958
  contributor:
    fullname: M Franchini
– volume: 14
  start-page: 401
  year: 2017
  ident: 1340_CR25
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2017.31
  contributor:
    fullname: Ž Reiner
– volume: 150
  start-page: 604
  year: 2009
  ident: 1340_CR17
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-150-9-200905050-00006
  contributor:
    fullname: AS Levey
– volume: 14
  start-page: 939
  year: 2013
  ident: 1340_CR22
  publication-title: Obes Rev
  doi: 10.1111/obr.12064
  contributor:
    fullname: GA Christou
– volume: 42
  start-page: S124
  issue: suppl 1
  year: 2019
  ident: 1340_CR18
  publication-title: Diabetes Care
  doi: 10.2337/dc19-S011
  contributor:
    fullname: American Diabetes Association
– volume: 41
  start-page: 111
  year: 2020
  ident: 1340_CR27
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehz455
  contributor:
    fullname: F Mach
– volume: 42
  start-page: 2342
  year: 2017
  ident: 1340_CR24
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000480006
  contributor:
    fullname: Y Chen
– volume: 62
  start-page: 699
  year: 2016
  ident: 1340_CR14
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2015.248625
  contributor:
    fullname: A Tripodi
– volume: 33
  start-page: 4
  year: 2003
  ident: 1340_CR15
  publication-title: Pathophysiol Haemost Thromb
  doi: 10.1159/000071636
  contributor:
    fullname: HC Hemker
– ident: 1340_CR2
  doi: 10.3390/ijms18061321
– volume: 37
  start-page: 45
  year: 2014
  ident: 1340_CR11
  publication-title: J Thromb Thrombolysis
  doi: 10.1007/s11239-013-1026-5
  contributor:
    fullname: J Kalz
– volume: 20
  start-page: 1190
  year: 2019
  ident: 1340_CR21
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20051190
  contributor:
    fullname: H Yanai
– volume: 270
  start-page: 26746
  year: 1995
  ident: 1340_CR1
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.45.26746
  contributor:
    fullname: PE Scherer
– volume: 18
  start-page: 227
  year: 2019
  ident: 1340_CR10
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-019-1168-3
  contributor:
    fullname: L Yang
– volume: 219
  start-page: 322
  year: 2011
  ident: 1340_CR20
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2011.07.011
  contributor:
    fullname: T Pischon
SSID ssj0037387
Score 2.3515136
Snippet Objective Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in...
Previous studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in patients with...
ObjectivePrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in...
OBJECTIVEPrevious studies showed a significant association between lower plasma adiponectin levels and higher risk of adverse cardiovascular outcomes in...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 547
SubjectTerms Adiponectin
Adipose tissue
Cardiovascular diseases
Diabetes
Diabetes mellitus (non-insulin dependent)
Endocrinology
Hemoglobin
Insulin
Internal Medicine
Medicine
Medicine & Public Health
Metabolic Diseases
Original Article
Plasma
Thrombin
Triglycerides
Title Association between lower plasma adiponectin levels and higher plasma thrombin generation parameters in men with type 2 diabetes: role of plasma triglycerides
URI https://link.springer.com/article/10.1007/s40618-020-01340-3
https://www.ncbi.nlm.nih.gov/pubmed/32588382
https://www.proquest.com/docview/2488692285
https://search.proquest.com/docview/2418127608
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4VkCoutKX8BGhlpN5KEGvHa5sbane7RcClVOotcmJ7QbDZFWEPvAzP2hlvkraiPdBTDnYmjmc8M54Zfwb4kIXMHknu0uC5SjNV9FJd8H4aQtDBeCf6EYlp9E1d_NCfBwSTI7rQRXVz2GYko6LuzrqR5dEp7XbQa8lQeSzBCtoeicK9cjI4HZ21CpiwelRzPubvb_5pg544lk-SotHWDF_91yhfw1rjWrKThSy8gRe-WoeX503y_C08_sYK1tRnsVu6JY3N0IeeWGbd9WxakQrEBqomqpmtHLuKtSBtJ7pYYYL7aTaOiNWRGgGIT6iwpmbYMEG6FN9lFN9lnLXx3WNGtYxsGjpSd9fj24cSF4Hz9QZ8Hw4uP43S5nqGtBRK3qeltDxTJvRKbbjvuUJb65XyQThRFJaw5rQJ3ojMc8mDRMfEFFKgANjSePSENmG5wp_aBmYJtKdwATdjPEOjapCu0QX2lR6Np0vgY8uwfLZA4cg7vOU45TlOeR6nPBcJ7LU8zZsVWeccNVXfcK5lAvtdM64lSpDYyk_n1If8HdU_0glsLWSh-5zgUmuheQIHLed_Ef_3WHae130XVjkVzcQitz1Yvr-b-3ewVLv5-0bK6fn18svwJ7t5-wY
link.rule.ids 315,782,786,27933,27934,41073,42142,48344,48347,49649,49652,52153
linkProvider Springer Nature
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RVgIuvB-hLRiJG0Tq-hHbvVXQZSvaXrpI3CIntkulbnbVdA_8GX4rM94kFJUe2rOdSeIZz4w9nz8DfJBRuh3FfR4D17nU1Sg3FS_yGKOJNnhRJCamyYk-_mG-7BNNjuzPwiS0e1-STJ56OOxGocfktNzBtEWi91iDDWkLiba8sXcw_TruPTCR9ejugMz_n_w3CF3LLK9VRVOwGT--22c-gUddcsn2VtbwFO6F5hncP-rK58_h9xVlsA6hxc7pnjS2wCx65pjzZ4t5Q04QGwhP1DLXePYzoUH6TnS1wgxX1Ow0cVYnaUQhPiNoTcuwYYZyaYeX0Q4v46zf4d1lhGZk8ziIujg7Pf9V4zTwoX0B38f708-TvLugIa-FVpd5rRyX2sZRbSwPI18Z54LWIQovqsoR25yxMVghA1c8KkxNbKUEmoCrbcBc6CWsN_hTr4E5ou2pfMTlGJcYVi3KtabCvipg-PQZfOw1Vi5WPBzlwLichrzEIS_TkJcig61eqWU3J9uSo68qLOdGZfB-aMbZRCUS14T5kvpQxqOLHZPBq5UxDK8TXBkjDM_gU6_5v8Jv_pY3t-v-Dh5MpkeH5eHB8bdNeMgJQpMgb1uwfnmxDNuw1vrl287k_wDguf1o
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB4VkFAv0AKlobQ1ErcSwdrx2u4NlV1tC0VIFIlb5MQ2RWKzK7J74GX6rJ3xJikV7aHq2ZNJYo_nxzPzGWA_C5k9ktylwXOVZqropbrg_TSEoIPxTvQjEtPoUp1f65MBweR0Xfyx2r1NSS56GgilqZodTl047BrfyAzplEIfdGEy1CRLsJJhJIOSvnI8-DI6a7UxAfeoplnmz0_-bpCeeJlPMqTR8AzX__-TX8Ba43Sy44WUvIRnvtqA1a9NWn0TfjxaJNZUbrE7uj-NTdG7Hltm3e10UpFyxAGqM6qZrRz7HqtEWiK6cmGMkTa7iVjWkRtBi4-p5KZmODBGvnTyy-jkl3HWnvx-ZFTlyCahY3V_e3P3UOL2cL7egqvh4NunUdpc3JCWQslZWkrLM2VCr9SG-54rtLVeKR-EE0VhCYVOm-CNyDyXPEh0WUwhBYqGLY1HH-kVLFf4U6-BWYLzKVzAMI1naG4N8jW6QFrp0ay6BD60q5dPF_gceYfEHKc8xynP45TnIoHddoHzZq_WOUcd1jeca5nAXjeMu4xSJ7bykznRkCek-kc6ge2FYHSvE1xqLTRP4KCVgl_M__4tO_9G_h5WL06G-dnn89M38JxTZU2shNuF5dn93L-FpdrN3zXS_xPDUwY6
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+lower+plasma+adiponectin+levels+and+higher+plasma+thrombin+generation+parameters+in+men+with+type+2+diabetes%3A+role+of+plasma+triglycerides&rft.jtitle=Journal+of+endocrinological+investigation&rft.au=Mantovani%2C+A.&rft.au=Danese%2C+E.&rft.au=Salvagno%2C+G.+L.&rft.au=Gelati%2C+M.&rft.date=2021-03-01&rft.pub=Springer+International+Publishing&rft.eissn=1720-8386&rft.volume=44&rft.issue=3&rft.spage=547&rft.epage=555&rft_id=info:doi/10.1007%2Fs40618-020-01340-3&rft.externalDocID=10_1007_s40618_020_01340_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1720-8386&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1720-8386&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1720-8386&client=summon